Month: October 2020

New FDA Label Suggested for Breast Implants

On September 29, 2020, the U.S. Food and Drug Administration (FDA) released final labeling recommendations aimed at improving patients’ understanding of the risk associated with breast implant surgery. The non-binding recommendations highlight the ongoing failure by manufacturers to adequately disclose the risks associated with breast implants to patients and their doctors. The labeling requirements specifically …

New FDA Label Suggested for Breast Implants Read More »

Elmiron Eye Injury MDL Formation on the Horizon

Elmiron attorneys are pushing the Judicial Panel on Multidistrict Litigation to create a Multi-District Litigation (MDL) in the U.S. District Court of New Jersey to consolidate pretrial discovery and related proceedings. Due to the widespread number of patients suffering from eye injuries, experts expect the number of Elmiron lawsuits to grow significantly over the coming …

Elmiron Eye Injury MDL Formation on the Horizon Read More »

J&J Settles 1,000 Talc Powder Claims for $100 Million

In a landmark settlement, Johnson & Johnson agreed to pay out over $100 million to resolve more than 1,000 lawsuits which claim the company’s talcum powder-based products like baby powder caused cancer. The long-awaited announcement will begin to resolve years of litigation involving over 20,000 cancer victims. The agreement marks the first time J&J has …

J&J Settles 1,000 Talc Powder Claims for $100 Million Read More »